C26H29FN2O2
Neat
420.53
Room Temperature
105452-52-6; UNII-LZ96QV2C42; LZ96QV2C42; (3S, 4S)-Levocabastine; R 64034; (3S, 4S)-1-(cis-4-Cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenylpiperidine-4-carboxylic acid; (3S, 4S)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid; 4-Piperidinecarboxylic acid, 1-(cis-4-cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-, (3S, 4S)-; Levocabastine impurity 25; SCHEMBL728715; DTXSID80861015; Levocabastine EP Impurity I (Free Base); Levocabastine hydrochloride impurity I [EP]; LEVOCABASTINE HYDROCHLORIDE IMPURITY I [EP IMPURITY]; 4-PIPERIDINECARBOXYLIC ACID, 1-(4-CYANO-4-(4-FLUOROPHENYL)CYCLOHEXYL)-3-METHYL-4-PHENYL-, (3S-(1(CIS), 3.ALPHA., 4.ALPHA.))-; 4-Piperidinecarboxylic acid, 1-(4-cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-, (3S-(1(cis), 3alpha and 4alpha))-
(3S and 4S)-1-[4-cyano-4-(4-fluorophenyl)cyclohexyl]-3-methyl-4-phenylpiperidine-4-carboxylic acid
InChI=1S/C26H29FN2O2/c1-19-17-29(16-15-26(19,24(30)31)21-5-3-2-4-6-21)23-11-13-25(18-28,14-12-23)20-7-9-22(27)10-8-20/h2-10,19,23H,11-17H2,1H3,(H,30,31)/t19-,23?,25?,26+/m1/s1